
Pfizer’s big fat fail 12/1/23
Selam
48 min
Business & Finance
Description
<p>Pfizer shares sinking to March 2020 lows after the company halted its twice-daily weight loss pill. Just how big of a setback is this for the pharma heavyweight’s entry into the obesity drug race? The Fast Money traders debate.</p><p> </p><p><a href="https://www.cnbc.com/fast-money-disclaimer/"><strong>Fast Money Disclaimer</strong></a></p>
Uploader
Episodes
1
Pfizer’s big fat fail 12/1/23
Selam